“Uso de medicamentos ‘da classe Glucagon-Like Peptide-1 (GLP-1), do Ozempic e, Mounjaro’ na causa de pancreatite aguda”, RSD, vol. 14, nº 11, p. e119141150085, nov. 2025, doi: 10.33448/rsd-v14i11.50085.